<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the distribution of various anti-anionic and anti-cofactor <z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies in children with <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">kala-azar</z:e>, and to compare them to <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>, <z:e sem="disease" ids="C0040558" disease_type="Disease or Syndrome" abbrv="">toxoplasmosis</z:e> and auto-<z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immune disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: The frequency and the concentration of antibodies against <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (aCL), phosphatidylserine (aPS), phosphatidylinositol (aPI), <z:chebi fb="0" ids="16337">phosphatidic acid</z:chebi> (aPA), Beta2GPI (anti-Beta2GPI), prothrombin (aPT), annexin V (aAnnV), protein C (aPnC) and protein S (aPnS) were studied in sera from 103 children with <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">kala-azar</z:e> and compared with <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> (n=32), <z:e sem="disease" ids="C0040558" disease_type="Disease or Syndrome" abbrv="">toxoplasmosis</z:e> (n=31), <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) (n=40) and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) (n=35) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The prevalence of aCL, aPS, aPI, aPA, anti-Beta2GPI, aPT, aAnnV, aPnC and aPnS was 54%, 56%, 43%, 28%, 73%, 67%, 55%, 30%, 25%, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Ninety-three per cent of children with <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">kala-azar</z:e> (96/103) had one or more aPL specificities, but none had thromboses </plain></SENT>
<SENT sid="4" pm="."><plain>The spectrum of aPL was quite similar to that found in patients with SLE and APS </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> are a frequent finding in <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">kala-azar</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The aPL produced mimic those found in <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>However, further studies are required to assess the exact role of these aPL during <z:e sem="disease" ids="C0023281" disease_type="Disease or Syndrome" abbrv="">leishmaniasis</z:e> </plain></SENT>
</text></document>